Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026)
Senseonics Holdings (SENS) reported Liabilities and Shareholders Equity of $102.9 million for Q1 2026, up 17.94% year-over-year from $87.2 million in Q1 2025, and down 18.54% quarter-over-quarter from $126.3 million in Q4 2025.
Senseonics Holdings (SENS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $102.9 million in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $102.9 million, up 17.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $519.3 million (up 31.29% YoY), and the FY2025 annual result was $126.3 million, up 25.72% from the prior year.
- Liabilities and Shareholders Equity slipped to $102.9 million in Q1 2026 per SENS's latest filing, from $126.3 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $188.1 million in Q1 2022 and troughed at $87.2 million in Q1 2025.
- A 5-year average of $139.4 million and a median of $139.9 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity sank 37.47% in 2024, then surged 45.25% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $177.7 million in 2022, then declined by 22.21% to $138.2 million in 2023, then declined by 27.33% to $100.4 million in 2024, then advanced by 25.72% to $126.3 million in 2025, then retreated by 18.54% to $102.9 million in 2026.
- Business Quant data shows SENS's Liabilities and Shareholders Equity at $102.9 million in Q1 2026, $126.3 million in Q4 2025, and $139.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Senseonics Holdings | 309.99 Mn | 245.67 Mn | 6.94 Mn | 102.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.86 Mn |
| Dec 31, 2025 | 126.27 Mn |
| Sep 30, 2025 | 139.92 Mn |
| Jun 30, 2025 | 150.27 Mn |
| Mar 31, 2025 | 87.21 Mn |
| Dec 31, 2024 | 100.44 Mn |
| Sep 30, 2024 | 96.33 Mn |
| Jun 30, 2024 | 111.56 Mn |
| Mar 31, 2024 | 126.52 Mn |
| Dec 31, 2023 | 138.22 Mn |
| Sep 30, 2023 | 154.07 Mn |
| Jun 30, 2023 | 153.36 Mn |
| Mar 31, 2023 | 158.53 Mn |
| Dec 31, 2022 | 177.67 Mn |
| Sep 30, 2022 | 182.67 Mn |
| Jun 30, 2022 | 175.33 Mn |
| Mar 31, 2022 | 188.10 Mn |
| Dec 31, 2021 | 198.93 Mn |
| Sep 30, 2021 | 219.62 Mn |
| Jun 30, 2021 | 235.13 Mn |